Home » Newsletters » BioWorld Science

BioWorld Science

April 4, 2007

View Archived Issues

Emisphere reports data on oral delivery of GLP-1 and PYY

Alpharma licenses novel technology from Tris Pharma

Enzon studies HIF-1 alpha antagonist in phase I trial

Safety and pharmacokinetics established for XTL-6865 in HCV

MedImmune licenses reverse genetics intellectual property to sanofi pasteur

VioQuest adds two new products to pipeline

Athersys achieves commercial collaboration milestones

Pivotal study of romidepsin in CTCL cleared to continue

Takeda acquires rights to R-851 from 3M

Galapagos achieves milestones in GSK osteoarthritis collaboration

Development of Pevion's malaria vaccine supported by E.U. grant

Phase II study of LE-SN38 misses primary tumor response endpoint

Topical interferon alpha-2b shows clinically efficacious response in LSIL

Berlex reports on novel CCR5 antagonists

Recent patents impart new therapeutic agents for cancer

IND clearance sought for phase II ophthalmic study of Tbeta4 eye drops

Parkinson's disease drug pergolide withdrawn

EMEA recommends restrictions on use of Ketek

Lutetium-177-labeled monoclonal antibody cG250 appears safe in renal cell carcinoma

V-HeFT I and II formulations of isosorbide dinitrate/hydralazine not bioequivalent

Nicotine patch appears safe for use in coronary artery disease patients

Novel KCNQ2 channel opener shows antiepileptic activity in mice

Novel treatment options for inflammatory disorders claimed in recent GSK and Palau patents

Novel therapeutic agents for immunological disorders disclosed in recent patents

Cardiome Pharma updates status of key programs

Lucentis launched in the U.K.

Transition receives fast track designation for Alzheimer's disease drug candidate

Santen seeks European approval of tafluprost

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...